These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers. Garambois V; Glaussel F; Foulquier E; Ychou M; Pugnière M; Luo RX; Bezabeh B; Pèlegrin A BMC Cancer; 2004 Oct; 4():75. PubMed ID: 15488142 [TBL] [Abstract][Full Text] [Related]
48. Protein epitopes in carcinoembryonic antigen. Report of the ISOBM TD8 workshop. Bjerner J; Lebedin Y; Bellanger L; Kuroki M; Shively JE; Varaas T; Nustad K; Hammarström S; Børmer OP Tumour Biol; 2002; 23(4):249-62. PubMed ID: 12499780 [TBL] [Abstract][Full Text] [Related]
50. A reference of the GOLD classification of monoclonal antibodies against carcinoembryonic antigen to the domain structure of the carcinoembryonic antigen molecule. Murakami M; Kuroki M; Arakawa F; Kuwahara M; Oikawa S; Nakazato H; Matsuoka Y Hybridoma; 1995 Feb; 14(1):19-28. PubMed ID: 7768530 [TBL] [Abstract][Full Text] [Related]
51. Localization of GW-39 human tumors in hamsters by affinity-purified antibody to carcinoembryonic antigen. Primus FJ; Macdonald R; Goldenberg DM; Hansen HJ Cancer Res; 1977 May; 37(5):1544-7. PubMed ID: 851962 [TBL] [Abstract][Full Text] [Related]
52. Sensitivity and specificity of Gold types 1 to 5 anti-carcinoembryonic antigen monoclonal antibodies: immunohistologic characterization in colorectal cancer and normal tissues. Esteban JM; Paxton R; Mehta P; Battifora H; Shively JE Hum Pathol; 1993 Mar; 24(3):322-8. PubMed ID: 7681033 [TBL] [Abstract][Full Text] [Related]
53. Serologic mapping and biochemical characterization of the carcinoembryonic antigen epitopes using fourteen distinct monoclonal antibodies. Kuroki M; Greiner JW; Simpson JF; Primus FJ; Guadagni F; Schlom J Int J Cancer; 1989 Aug; 44(2):208-18. PubMed ID: 2474516 [TBL] [Abstract][Full Text] [Related]
54. Binding of five monoclonal anti-CEA antibodies with different epitope specificities to various carcinoma tissues. Wagener C; Petzold P; Köhler W; Totović V Int J Cancer; 1984 Apr; 33(4):469-75. PubMed ID: 6200447 [TBL] [Abstract][Full Text] [Related]
55. Novel super-high affinity sheep monoclonal antibodies against CEA bind colon and lung adenocarcinoma. Osborne J; Harrison P; Butcher R; Ebsworth N; Tan K Hybridoma; 1999 Apr; 18(2):183-91. PubMed ID: 10380018 [TBL] [Abstract][Full Text] [Related]
56. Monoclonal antibodies identify a CEA crossreacting antigen of 95 kD (NCA-95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kD. Buchegger F; Schreyer M; Carrel S; Mach JP Int J Cancer; 1984 May; 33(5):643-9. PubMed ID: 6724739 [TBL] [Abstract][Full Text] [Related]
57. A solid-phase mutual inhibition assay with labeled antigen. Kuroki M Methods Mol Biol; 2009; 524():59-66. PubMed ID: 19377936 [TBL] [Abstract][Full Text] [Related]
58. Monoclonal antibody COL-1 reacts with restricted epitopes on carcinoembryonic antigen: an immunohistochemical study. Shi ZR; Tacha D; Itzkowitz SH J Histochem Cytochem; 1994 Sep; 42(9):1215-9. PubMed ID: 7520463 [TBL] [Abstract][Full Text] [Related]
59. Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humans. Sharkey RM; Goldenberg DM; Goldenberg H; Lee RE; Ballance C; Pawlyk D; Varga D; Hansen HJ Cancer Res; 1990 May; 50(9):2823-31. PubMed ID: 2328505 [TBL] [Abstract][Full Text] [Related]
60. Production of monoclonal antibodies to serum antigens in colorectal carcinoma. Teh JG; Thompson CH; McKenzie IF J Immunol Methods; 1988 May; 110(1):101-9. PubMed ID: 3286775 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]